[
  {
    "patent_id": "US102951A1",
    "title": "insulin inflammation novel formulation and delivery mechanism",
    "assignee": "Johnson & Johnson",
    "inventors": [
      "Michael Lee",
      "Emily Zhang"
    ],
    "filing_year": 2015,
    "publication_year": 2021,
    "expiry_year": 2034,
    "therapeutic_area": "Inflammation",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced inflammation. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US694337A1",
    "title": "insulin pain management novel formulation and delivery mechanism",
    "assignee": "Dr. Reddyâ€™s Laboratories",
    "inventors": [
      "Michael Lee",
      "Emily Zhang"
    ],
    "filing_year": 2021,
    "publication_year": 2019,
    "expiry_year": 2035,
    "therapeutic_area": "Pain management",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced pain management. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US595513A1",
    "title": "insulin combination therapy novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "Priya Nair",
      "Anna Petrova"
    ],
    "filing_year": 2016,
    "publication_year": 2022,
    "expiry_year": 2032,
    "therapeutic_area": "Combination therapy",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced combination therapy. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US748697A1",
    "title": "insulin pediatric dosing novel formulation and delivery mechanism",
    "assignee": "Sun Pharma",
    "inventors": [
      "Amit Sharma",
      "Anna Petrova"
    ],
    "filing_year": 2022,
    "publication_year": 2020,
    "expiry_year": 2040,
    "therapeutic_area": "Pediatric dosing",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced pediatric dosing. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US181560A1",
    "title": "insulin liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "Sara Kim",
      "Emily Zhang"
    ],
    "filing_year": 2021,
    "publication_year": 2019,
    "expiry_year": 2034,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US689158A1",
    "title": "insulin liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "Amit Sharma",
      "Carlos Gomez"
    ],
    "filing_year": 2019,
    "publication_year": 2020,
    "expiry_year": 2031,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of insulin, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Expired",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  }
]